Association between type-2 diabetes mellitus and post-discharge outcomes in heart failure patients: Findings from the RICA registry

Diabetes Research and Clinical Practice

Volumn 104, Issue 3, 2014, Pages 410-419

  Carrasco Sánchez, Francisco Javier ^a   Gomez Huelgas, Ricardo ^b   Formiga, Francesc ^c   Conde Martel, Alicia ^d   Trullàs, Joan Carles ^e   Bettencourt, Paulo ^f   Arévalo Lorido, José Carlos ^g   Pérez Barquero, Manuel Montero ^h  

^a HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^e Hospital Sant Jaume de Calella   (Spain)

^f HOSPITAL DE SÃO JOÃO   (Portugal)

^g Hospital Comarcal de Zafra   (Spain)

^h UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Diabetes; Heart failure; Mortality; Prognosis

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; LOOP DIURETIC AGENT; ORAL ANTIDIABETIC AGENT;

ADULT; AGE; AGED; ANEMIA; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DISEASE REGISTRY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; HYPONATREMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PROGNOSIS; SPAIN;

DIABETES; HEART FAILURE; MORTALITY; PROGNOSIS;

AGED; ANEMIA; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; PATIENT DISCHARGE; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SPAIN; STROKE VOLUME; SURVIVAL RATE; VENTRICULAR FUNCTION, LEFT;

EID: 84902547627     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.03.015     Document Type: Article

References (44)

1. MacDonald M.R., Petrie M.C., Hawkins N.M., Petrie J.R., Fisher M., McKelvie R., et al. Diabetes, left ventricular systolic dysfunction, and chronic heart failure. Eur Heart J 2008, 29:1224-1240.
2. Nieminen M.S., Brutsaert D., Dickstein K., Drexler H., Follath F., Harjola V.P., et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006, 27:2725-2736.
3. Sarma S., Mentz R.J., Kwasny M.J., Fought A.J., Huffman M., Subacius H., et al. Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial. Eur J Heart Fail 2013, 15:194-202.
4. Kamalesh M., Cleophas T.J. Heart failure due to systolic dysfunction and mortality in diabetes: pooled analysis of 39,505 subjects. J Card Fail 2009, 15:305-309.
5. Gustafsson I., Brendorp B., Seibaek M., Burchardt H., Hildebrandt P., Kober L., et al. Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol 2004, 43:771-777.
6. MacDonald M.R., Petrie M.C., Varyani F., Ostergren J., Michelson E.L., Young J.B., et al. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur Heart J 2008, 29:1377-1385.
7. Andersson C., Weeke P., Pecini R., Kjaergaard J., Hassager C., Kober L., et al. Long-term impact of diabetes in patients hospitalized with ischemic and non-ischemic heart failure. Scand Cardiovasc J 2010, 44:37-44.
8. Berry C., Brett M., Stevenson K., McMurray J.J., Norrie J. Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure. Heart 2008, 94:296-304.
9. Parissis J.T., Rafouli-Stergiou P., Mebazaa A., Ikonomidis I., Bistola V., Nikolaou M., et al. Acute heart failure in patients with diabetes mellitus: clinical characteristics and predictors of in-hospital mortality. Int J Cardiol 2012, 157:108-113.
10. Fonarow G.C., Adams K.F., Abraham W.T., Yancy C.W., Boscardin W.J. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005, 293:572-580. ADHERE Scientific Advisory Committee SG, and Investigators.
11. Greenberg B.H., Abraham W.T., Albert N.M., Chiswell K., Clare R., Stough W.G., et al. Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 2007, 154. 277 e1-277 e8.
12. Perez-Calvo J.I., Montero-Perez-Barquero M., Camafort-Babkowski M., Conthe-Gutierrez P., Formiga F., Aramburu-Bodas O., et al. Influence of admission blood pressure on mortality in patients with acute decompensated heart failure. QJM 2011, 104:325-333.
13. Trullas J.C., Formiga F., Montero M., Conde A., Casado J., Carrasco F.J., et al. [Paradox of obesity in heart failure: results from the Spanish RICA Registry]. Med Clin (Barc) 2011, 137:671-677.
14. Casado J., Montero M., Formiga F., Camafort M., Sanchez C., Muela A., et al. [Renal function in patients with heart failure: prognostic value]. Rev Clin Esp 2012, 212:119-126.
15. Trullas J.C., Formiga F., Montero M., Carrera-Izquierdo M., Grau-Amoros J., Chivite-Guillen D., et al. Impact of weight loss on mortality in chronic heart failure: findings from the RICA Registry. Int J Cardiol 2012.
16. Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J., Ponikowski P., Poole-Wilson P.A., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology, Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008, 29:2388-2442.
17. American Diabetes A. Standards of medical care in diabetes-2013. Diabetes Care 2013, 36(Suppl 1):S11-S66.
18. McMurray J.J., Adamopoulos S., Anker S.D., Auricchio A., Bohm M., Dickstein K., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012, 14:803-869.
19. Manzano-Fernandez S., Flores-Blanco P.J., Perez-Calvo J.I., Ruiz-Ruiz F.J., Carrasco-Sanchez F.J., Morales-Rull J.L., et al. Comparison of risk prediction with the CKD-EPI and MDRD equations in acute decompensated heart failure. J Card Fail 2013, 19:583-591.
20. Adams K.F., Fonarow G.C., Emerman C.L., LeJemtel T.H., Costanzo M.R., Abraham W.T., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005, 149:209-216.
21. From A.M., Leibson C.L., Bursi F., Redfield M.M., Weston S.A., Jacobsen S.J., et al. Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med 2006, 119:591-599.
22. Domanski M., Krause-Steinrauf H., Deedwania P., Follmann D., Ghali J.K., Gilbert E., et al. The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial. J Am Coll Cardiol 2003, 42:914-922.
23. Egstrup M., Schou M., Gustafsson I., Kistorp C.N., Hildebrandt P.R., Tuxen C.D. Oral glucose tolerance testing in an outpatient heart failure clinic reveals a high proportion of undiagnosed diabetic patients with an adverse prognosis. Eur J Heart Fail 2011, 13:319-326.
24. Harjola V.P., Follath F., Nieminen M.S., Brutsaert D., Dickstein K., Drexler H., et al. Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure. Eur J Heart Fail 2010, 12:239-248.
25. Fang Z.Y., Prins J.B., Marwick T.H. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004, 25:543-567.
26. Andersson C., Gislason G.H., Weeke P., Hoffmann S., Hansen P.R., Torp-Pedersen C., et al. Diabetes is associated with impaired myocardial performance in patients without significant coronary artery disease. Cardiovasc Diabetol 2010, 9:3.
27. Egstrup M., Kistorp C.N., Schou M., Hofsten D.E., Moller J.E., Tuxen C.D., et al. Abnormal glucose metabolism is associated with reduced left ventricular contractile reserve and exercise intolerance in patients with chronic heart failure. Eur Heart J Cardiovasc Imaging 2013, 14:349-357.
28. Haas S.J., Vos T., Gilbert R.E., Krum H. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials. Am Heart J 2003, 146:848-853.
29. Shekelle P.G., Rich M.W., Morton S.C., Atkinson C.S., Tu W., Maglione M., et al. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol 2003, 41:1529-1538.
30. Vermes E., Ducharme A., Bourassa M.G., Lessard M., White M., Tardif J.C., et al. Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD). Circulation 2003, 107:1291-1296.
31. Yusuf S., Ostergren J.B., Gerstein H.C., Pfeffer M.A., Swedberg K., Granger C.B., et al. Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure. Circulation 2005, 112:48-53.
32. Andersson C., Norgaard M.L., Hansen P.R., Fosbol E.L., Schmiegelow M., Weeke P., et al. Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort study. Eur J Heart Fail 2010, 12:1333-1338.
33. Bakris G., Stockert J., Molitch M., Zhou Q., Champion A., Bacher P., et al. Risk factor assessment for new onset diabetes: literature review. Diabetes Obes Metab 2009, 11:177-187.
34. Gaede P., Lund-Andersen H., Parving H.H., Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008, 358:580-591.
35. Mebazaa A., Gayat E., Lassus J., Meas T., Mueller C., Maggioni A., et al. Association between elevated blood glucose and outcome in acute heart failure: results from an international observational cohort. J Am Coll Cardiol 2013, 61:820-829.
36. Turchin A., Matheny M.E., Shubina M., Scanlon J.V., Greenwood B., Pendergrass M.L. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care 2009, 32:1153-1157.
37. Dungan K.M., Binkley P., Nagaraja H.N., Schuster D., Osei K. The effect of glycaemic control and glycaemic variability on mortality in patients hospitalized with congestive heart failure. Diabetes Metab Res Rev 2011, 27:85-93.
38. Eurich D.T., Majumdar S.R., McAlister F.A., Tsuyuki R.T., Johnson J.A. Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care 2005, 28:2345-2351.
39. Eurich D.T., Weir D.L., Majumdar S.R., Tsuyuki R.T., Johnson J.A., Tjosvold L., et al. Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients. Circ Heart Fail 2013, 6:395-402.
40. Giles T.D., Miller A.B., Elkayam U., Bhattacharya M., Perez A. Pioglitazone and heart failure: results from a controlled study in patients with type 2 diabetes mellitus and systolic dysfunction. J Card Fail 2008, 14:445-452.
41. Erdmann E., Charbonnel B., Wilcox R.G., Skene A.M., Massi-Benedetti M., Yates J., et al. Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08). Diabetes Care 2007, 30:2773-2778.
42. Mundil D., Cameron-Vendrig A., Husain M. GLP-1 receptor agonists: a clinical perspective on cardiovascular effects. Diab Vasc Dis Res 2012, 9:95-108.
43. Murcia A.M., Hennekens C.H., Lamas G.A., Jimenez-Navarro M., Rouleau J.L., Flaker G.C., et al. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. Arch Intern Med 2004, 164:2273-2279.
44. Gerstein H.C., Bosch J., Dagenais G.R., Diaz R., Jung H., Maggioni A.P., et al. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med 2012, 367:319-328.